These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23995209)

  • 41. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Depressive pseudodementia in early Parkinson's disease: lessons from a case with long-term follow-up].
    Giménez-Roldán S; Mateo D; Dobato JL
    Neurologia; 1997 Mar; 12(3):130-5. PubMed ID: 9198454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.
    Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evolution of mild cognitive impairment in Parkinson disease.
    Broeders M; de Bie RM; Velseboer DC; Speelman JD; Muslimovic D; Schmand B
    Neurology; 2013 Jul; 81(4):346-52. PubMed ID: 23794682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.
    Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH
    Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving the diagnostic accuracy of the RBANS in mild cognitive impairment with construct-consistent measures.
    Heyanka DJ; Scott JG; Adams RL
    Appl Neuropsychol Adult; 2015; 22(1):32-41. PubMed ID: 25529589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can a virtual reality cognitive training application fulfill a dual role? Using the virtual supermarket cognitive training application as a screening tool for mild cognitive impairment.
    Zygouris S; Giakoumis D; Votis K; Doumpoulakis S; Ntovas K; Segkouli S; Karagiannidis C; Tzovaras D; Tsolaki M
    J Alzheimers Dis; 2015; 44(4):1333-47. PubMed ID: 25428251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of a relationship between subjective memory complaint and objective memory impairment in mild cognitive impairment (MCI): is it time to abandon subjective memory complaint as an MCI diagnostic criterion?
    Lenehan ME; Klekociuk SZ; Summers MJ
    Int Psychogeriatr; 2012 Sep; 24(9):1505-14. PubMed ID: 22717042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease.
    Lee YM; Park JM; Lee BD; Moon E; Chung YI; Kang CJ
    Dement Geriatr Cogn Disord; 2012; 33(4):240-4. PubMed ID: 22738930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can mild cognitive impairment be accurately diagnosed in english speakers from linguistic minorities? Results from the Sydney Memory and Ageing study.
    Low LF; Harrison F; Kochan NA; Draper B; Slavin MJ; Reppermund S; Sachdev PS; Brodaty H
    Am J Geriatr Psychiatry; 2012 Oct; 20(10):866-77. PubMed ID: 22261551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical characteristics of 2,789 consecutive patients in a memory clinic in China.
    Wang B; Guo QH; Chen MR; Zhao QH; Zhou Y; Hong Z
    J Clin Neurosci; 2011 Nov; 18(11):1473-7. PubMed ID: 21924913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mild cognitive impairment: hope for stability, plan for progression.
    Patel BB; Holland NW
    Cleve Clin J Med; 2012 Dec; 79(12):857-64. PubMed ID: 23208990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mild cognitive impairment in Parkinson's disease: millstone or milestone?
    Burn DJ; Barker RA
    Pract Neurol; 2013 Apr; 13(2):68-9. PubMed ID: 23468557
    [No Abstract]   [Full Text] [Related]  

  • 56. The use of the integrated cognitive assessment to improve the efficiency of primary care referrals to memory services in the accelerating dementia pathway technologies study.
    Modarres MH; Kalafatis C; Apostolou P; Tabet N; Khaligh-Razavi SM
    Front Aging Neurosci; 2023; 15():1243316. PubMed ID: 37781102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The treatment of mild cognitive impairment associated with Parkinson's disease.
    Burn DJ
    Mov Disord; 2015 Jun; 30(7):881-2. PubMed ID: 26011710
    [No Abstract]   [Full Text] [Related]  

  • 58. The role of the neuropsychologist in memory clinics.
    Salvadori E; Pantoni L;
    Neurol Sci; 2020 Jun; 41(6):1483-1488. PubMed ID: 31950460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacological therapeutic intervention in mild cognitive impairment].
    Arriola Manchola E; Alaba Loinaz J
    Rev Esp Geriatr Gerontol; 2017 Jun; 52 Suppl 1():39-43. PubMed ID: 29628033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lithium-induced cognitive dysfunction assessed over 1-year hospitalisation: A case report.
    Murase Y; Kato M; Kinoshita T; Takekita Y
    S Afr J Psychiatr; 2024; 30():2314. PubMed ID: 39363941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.